Arvee Laboratories (India) Limited Cash Flow Conversion Efficiency

Latest as of September 2025: 0.043x

Arvee Laboratories (India) Limited cash flow conversion efficiency. Based on the latest financial reports, Arvee Laboratories (India) Limited (ARVEE) has a cash flow conversion efficiency ratio of 0.043x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs13.56 Million ≈ $146.61K USD) by net assets (Rs314.41 Million ≈ $3.40 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Arvee Laboratories (India) Limited (2013–2025)

Cash flow conversion efficiency of Arvee Laboratories (India) Limited from 2013 to 2025. This chart illustrates how Arvee Laboratories (India) Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Arvee Laboratories (India) Limited for real-time trading data and today's change.

Arvee Laboratories (India) Limited Cash Flow Conversion Ratio Explained

Arvee Laboratories (India) Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Arvee Laboratories (India) Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Arvee Laboratories (India) Limited ranked by their cash flow conversion efficiency. Also see Arvee Laboratories (India) Limited (ARVEE) market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Hoftex Group AG
MU:NBH
0.032x
SP Systems Co.Ltd
KQ:317830
0.010x
Aligned Genetics Inc
KQ:238120
-0.058x
Genoray Co. Ltd
KQ:122310
0.057x
Valor Energy Inc.
NASDAQ:VAI
0.025x
Australis Oil & Gas Ltd
AU:ATS
0.083x
THE INX DIGITAL CO.INC.
F:FN4
N/A
JPMorgan American Investment Trust
LSE:JAM
0.003x

Annual Cash Flow Conversion Efficiency for Arvee Laboratories (India) Limited (2013–2025)

The table below shows the annual cash flow conversion efficiency of Arvee Laboratories (India) Limited from 2013 to 2025. Review Arvee Laboratories (India) Limited free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs312.61 Million
≈ $3.38 Million
Rs1.19 Million
≈ $12.86K
0.004x -96.98%
2024-03-31 Rs291.14 Million
≈ $3.15 Million
Rs36.64 Million
≈ $396.20K
0.126x +20.56%
2023-03-31 Rs280.62 Million
≈ $3.03 Million
Rs29.29 Million
≈ $316.75K
0.104x +266.76%
2022-03-31 Rs239.42 Million
≈ $2.59 Million
Rs6.81 Million
≈ $73.68K
0.028x -64.33%
2021-03-31 Rs214.38 Million
≈ $2.32 Million
Rs17.11 Million
≈ $184.99K
0.080x -85.57%
2020-03-31 Rs186.89 Million
≈ $2.02 Million
Rs103.34 Million
≈ $1.12 Million
0.553x -3.74%
2019-03-31 Rs164.62 Million
≈ $1.78 Million
Rs94.56 Million
≈ $1.02 Million
0.574x +35.56%
2018-03-31 Rs141.99 Million
≈ $1.54 Million
Rs60.16 Million
≈ $650.63K
0.424x -44.76%
2017-03-31 Rs41.94 Million
≈ $453.55K
Rs32.17 Million
≈ $347.88K
0.767x -67.47%
2016-03-31 Rs26.41 Million
≈ $285.60K
Rs62.26 Million
≈ $673.36K
2.358x -61.19%
2015-03-31 Rs14.15 Million
≈ $153.01K
Rs85.94 Million
≈ $929.39K
6.074x +6203.72%
2014-03-31 Rs30.62 Million
≈ $331.12K
Rs-3.05 Million
≈ $-32.95K
-0.100x -100.24%
2013-03-31 Rs930.00K
≈ $10.06K
Rs38.55 Million
≈ $416.93K
41.454x --

About Arvee Laboratories (India) Limited

NSE:ARVEE India Specialty Chemicals
Market Cap
$25.05 Million
Rs2.32 Billion INR
Market Cap Rank
#24220 Global
#1327 in India
Share Price
Rs210.15
Change (1 day)
+1.66%
52-Week Range
Rs133.86 - Rs290.78
All Time High
Rs306.70
About

Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroi… Read more